"The back and forth arguments are frustrating and, frankly, unacceptable"
USA: Still no clarity on rising insulin costsUS Congress Oversight and Investigations Subcommittee holds second hearing on the insulin pricing crisis in the US.
> Read more
US Congress Oversight and Investigations Subcommittee holds second hearing on the insulin pricing crisis in the US.
> Read moreJDRF International Board of Directors unanimously approves the appointment of Aaron J. Kowalski, Ph.D., to serve as its new President and CEO.
> Read more